Literature DB >> 2676919

A sequential double immunoenzymic staining procedure to obtain cell kinetic information in normal and hyperproliferative epidermis.

P E Van Erp1, S De Mare, J J Rijzewijk, P C Van de Kerkhof, F W Bauer.   

Abstract

A sequential double immunoenzymic staining procedure was developed using the monoclonal antibody anti-BrdUrd and Ki67 in order to determine whether hyperproliferative skin disorders, such as psoriasis, are characterized by an increased growth fraction rather than a much shorter cell cycle time of all germinative cells. Ki67 binds to a proliferation-associated nuclear antigen in a variety of human cell types, and anti-BrdUrd can be used to identify DNA-synthesizing cells. Although in hyperproliferative epidermis the absolute numbers of BrdUrd-positive cells as well as Ki67-positive cells were grossly increased, the ratio of these values was not changed compared to the ratio found in the epidermis of the clinically uninvolved skin of psoriatic patients and in normal epidermis. This suggests an increased growth fraction in hyperproliferative epidermis. Our data show that immunohistochemical double-staining techniques can be a valuable tool in the study of cell cycle kinetics in epithelial tissues.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2676919     DOI: 10.1007/bf01798497

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  13 in total

1.  Flow cytometric analysis of the recruitment of G0 cells in human epidermis in vivo following tape stripping.

Authors:  J B Boezeman; F W Bauer; R M de Grood
Journal:  Cell Tissue Kinet       Date:  1987-01

2.  The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology.

Authors:  P C Burger; T Shibata; P Kleihues
Journal:  Am J Surg Pathol       Date:  1986-09       Impact factor: 6.394

3.  Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.

Authors:  J Gerdes; H Lemke; H Baisch; H H Wacker; U Schwab; H Stein
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

4.  Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation.

Authors:  J Gerdes; U Schwab; H Lemke; H Stein
Journal:  Int J Cancer       Date:  1983-01-15       Impact factor: 7.396

5.  Cell kinetic basis for pathophysiology of psoriasis.

Authors:  G D Weinstein; J L McCullough; P A Ross
Journal:  J Invest Dermatol       Date:  1985-12       Impact factor: 8.551

6.  Synchronized growth in human epidermis following tape-stripping: its implication for cell kinetic studies.

Authors:  J J Rijzewijk; J B Boezeman; F W Bauer
Journal:  Cell Tissue Kinet       Date:  1988-07

7.  Psoriasis: maintenance of an intact monolayer basal cell differentiation compartment in spite of hyperproliferation.

Authors:  I M Leigh; K A Pulford; F C Ramaekers; E B Lane
Journal:  Br J Dermatol       Date:  1985-07       Impact factor: 9.302

8.  Determination of growth fractions in benign breast disease (BBD) with monoclonal antibody Ki-67.

Authors:  R J Lellé; W Heidenreich; G Stauch; I Wecke; J Gerdes
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

9.  Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication.

Authors:  H G Gratzner
Journal:  Science       Date:  1982-10-29       Impact factor: 47.728

10.  The use of FITC-conjugated monoclonal antibodies for determination of S-phase cells with fluorescence microscopy.

Authors:  N Gunduz
Journal:  Cytometry       Date:  1985-11
View more
  7 in total

1.  Epidermal kinetic alterations required to generate the psoriatic phenotype: a reappraisal.

Authors:  T Simonart; M Heenen; O Lejeune
Journal:  Cell Prolif       Date:  2010-06       Impact factor: 6.831

2.  Keratin 17: a useful marker in anti-psoriatic therapies.

Authors:  E M de Jong; I M van Vlijmen; P E van Erp; F C Ramaekers; S M Troyanovski; P C van de Kerkhof
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

3.  Repeated tape stripping of normal skin: a histological assessment and comparison with events seen in psoriasis.

Authors:  M J Gerritsen; P E van Erp; I M van Vlijmen-Willems; L T Lenders; P C van de Kerkhof
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

4.  The growth and differentiation of human keratinocytes in vitro: a combined immunohistochemical and flow cytometric study.

Authors:  P E van Erp; G J de Jongh; J B Boezeman; J Schalkwijk
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

5.  Accurate determination of S-phase fraction in proliferative cells by dual fluorescence and peroxidase immunohistochemistry with 5-bromo-2'-deoxyuridine (BrdU) and Ki67 antibodies.

Authors:  Rina Tanaka; Motomi Tainaka; Takumi Ota; Naoki Mizuguchi; Hiroyuki Kato; Shoichi Urabe; Yulin Chen; Jean-Michel Fustin; Yoshiaki Yamaguchi; Masao Doi; Shinshichi Hamada; Hitoshi Okamura
Journal:  J Histochem Cytochem       Date:  2011-05-06       Impact factor: 2.479

6.  Epidermal differentiation characteristics of the psoriatic plaque during treatment with calcipotriol.

Authors:  C J van der Vleuten; E M de Jong; P C van de Kerkhof
Journal:  Arch Dermatol Res       Date:  1996-06       Impact factor: 3.017

7.  Pigment-independent cAMP-mediated epidermal thickening protects against cutaneous UV injury by keratinocyte proliferation.

Authors:  Timothy L Scott; Perry A Christian; Melissa V Kesler; Kevin M Donohue; Brent Shelton; Kazumasa Wakamatsu; Shosuke Ito; John D'Orazio
Journal:  Exp Dermatol       Date:  2012-10       Impact factor: 3.960

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.